Welcome to our dedicated page for MEDLINE news (Ticker: MDLN), a resource for investors and traders seeking the latest updates and insights on MEDLINE stock.
Medline Inc. (Nasdaq: MDLN) is a healthcare company focused on medical-surgical ("med-surg") products and supply chain solutions that serve hospitals, surgery centers, physician offices and post-acute care facilities. The Medline news page on Stock Titan highlights company announcements that explain how it operates as what it describes as the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products.
News related to Medline often centers on capital markets activity and corporate milestones, such as the public filing of its registration statement on Form S-1 with the U.S. Securities and Exchange Commission, the pricing of its upsized initial public offering of Class A common stock, and the closing of that upsized offering on the Nasdaq Global Select Market under the symbol MDLN. These updates provide context on Medline’s transition to being a publicly traded company and its use of offering proceeds for debt repayment, general corporate purposes and transactions with pre-IPO owners.
Investors and observers can also find Medline announcements about participation in major healthcare and investor conferences, such as the J.P. Morgan Healthcare Conference. Such events can offer additional insight into how the company presents its med-surg product portfolio, supply chain capabilities and clinical solutions to the investment community.
This news page aggregates these types of press releases and corporate communications so readers can review Medline’s official statements over time. For anyone tracking MDLN, the page offers a focused view of the company’s own disclosures about its business focus, public listing, capital structure and engagement with the broader healthcare and financial markets.
Medline (Nasdaq: MDLN) announced a strategic agreement to pilot the Symbotic System, an AI-enabled robotics warehouse automation platform, at one of its 45 U.S. distribution centers in 2027. The pilot marks Medline's first deployment of this technology in healthcare to boost speed, accuracy, scalability and employee safety.
The Symbotic System automates depalletizing, singulation, storage/retrieval and smart outbound pallet building to modernize fulfillment across Medline's vertically integrated supply chain.
Medline (Nasdaq: MDLN) will report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and supplemental materials will be issued before market open, followed by a webcast and conference call at 9:30am ET / 8:30am CT.
Investors can access the live webcast, supplemental materials, and a replay on Medline’s Events page at the company investor relations website.
Medline (Nasdaq: MDLN) launched Pick Pack Pro™, a combined robotic, conveyor and packing fulfillment system at its Montgomery, N.Y. distribution center on April 6, 2026.
The system integrates optimized order batching, robotic sortation and automated packing to improve delivery speed and accuracy for health plan members. Medline plans rollout across its network of 45 distribution centers.
Medline (Nasdaq: MDLN) announced its Golden Cone Awards on April 3, 2026, recognizing top safety performance at 17 U.S. manufacturing facilities across three size tiers.
Awards were based on monthly safety metrics, employee safety engagement, and execution of an annual safety plan. 2025 recipients: Tier 1 North Mankato MN, Tier 2 Arlington Heights IL (third consecutive year), and Tier 3 Laredo TX. Medline delivers ~335,000 products, including ~190,000 unique Medline Brand items.
Medline (Nasdaq: MDLN) received two Healthcare Industry Resiliency Collaborative (HIRC) member-choice awards on April 1, 2026: the Highest Member Choice Award for Supplier Partnership and the Distinguished Member Choice Award for Resiliency, and renewed its HIRC Transparency Badge.
These nominations reflect provider recognition for long-term partnership, operational rigor, contingency readiness, and shared, standardized supply-chain visibility.
Medline (Nasdaq: MDLN) broke ground on a new 1.2 million sq. ft. distribution center in Midlothian, Texas, expanding its U.S. network of 45 distribution centers. The facility is expected to be fully operational in Q2 2027 and will include advanced automation such as AutoStore.
The site is Medline's second in the Dallas–Fort Worth area, supports next-day delivery to 95% of U.S. customers, and follows the company’s December 2025 initial public offering.
Medline (Nasdaq: MDLN) closed a secondary offering on March 10, 2026, in which 86,250,000 shares of Class A common stock were sold by selling stockholders at $41.00 per share, and underwriters fully exercised an option to purchase up to 11,250,000 additional shares.
The company did not sell any shares in the offering and did not receive proceeds; the offering was managed by global coordinators including Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan.
Medline (Nasdaq: MDLN) announced its 2025 Distribution Center of the Year and SAFE Award winners, recognizing top-performing U.S. distribution centers across four size tiers. The awards evaluate safety, service, quality, cost and people, and emphasize recordable safety incidents as the primary SAFE metric.
The company operates a 45-center U.S. network and says it provides next-day delivery to 95% of U.S. customers; Richmond, Virginia won both awards.
Medline (Nasdaq: MDLN) priced a secondary offering of 75,000,000 Class A shares at $41.00 per share by selling stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman and ADIA. Underwriters have a 30-day option for an additional 11,250,000 shares.
The offering is expected to close on March 10, 2026. Medline is not selling shares and will not receive proceeds; shares are being sold by the identified selling stockholders.
Medline (Nasdaq: MDLN) announced that certain selling stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman and a subsidiary of Abu Dhabi Investment Authority have commenced an underwritten public offering of 75,000,000 shares of Class A common stock on March 3, 2026.
Underwriters have a 30-day option to purchase up to an additional 11,250,000 shares. Medline will not sell shares and will not receive any proceeds from this offering.